EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences (EW) tumbles as guidance misses expectations
October 26, 2023 10:07 AM EDTEdwards Lifesciences (NYSE: EW) shares tumbled over 8% in after-hours trading after the company's latest earnings and guidance announcement disappointed investors and analysts alike.
After Wednesday's close, the company reported Q3 earnings of $0.59 per share, in line with the analyst estimate of $0.59. Revenue for the quarter was also in line, coming in at $1.48 billion, although that was a 12%... More
Edwards Lifesciences (EW) Reports In-Line Q3 EPS
October 25, 2023 4:16 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.
GUIDANCE:
Edwards Lifesciences sees Q4 2023 revenue of $1.45-1.53 billion, versus the consensus of... More
